The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) and the New Zealand Society of Gastroenterology (NZSG) are organising the 2019 InSiGHT Meeting, to be held in New Zealand for the first time from 20 to 23 March.
Dr Gabriel Capella, director of the Hereditary Cancer Program at the Catalan Institute of Oncology (ICO) is one of this year’s guest speakers. Their research focuses on studying the genetic basis of gastrointestinal cancer, with a particular interest in hereditary colorectal cancer. He took part in the Research Challenges Programme awarded to GoodGut by the Spanish Ministry of Economy and Competitiveness in 2016. After three years of study, the results will be presented at the 2019 InSiGHT Meeting on 21 March under the title RAID-LS: A non-invasive tool based on faecal bacterial signature for Lynch Syndrome surveillance.
Lynch syndrome is an inherited condition that increases risk of colon cancer, endometrial cancer and several other cancers. Doctors estimate that around 3 out of every 100 colon cancers or endometrial cancers are caused this syndrome.
Date: 20-23 March, 2019
Place: Skycity Auckland Convention Centre (New Zealand)
